Clinical and immunological assessment of children with ataxia telangiectasia attending Sohag university hospital in Upper Egypt

The Egyptian Journal of Immunology
Volume 28 (4) ,October , 2021
Pages: 272–281.
www.Ejimmunology.org
https://doi.org/10.55133/eji.280428
Eman M. Fahmy1, Eman H. Salama2, Mohamed A. El-Mokhtar3 and Abdelrahim A. Sadek1

 

1Department of Pediatric, Faculty of Medicine, Sohag University, Sohag, Egypt.

2Department of Clinical Pathology, Faculty of Medicine, Sohag University, Sohag, Egypt.

3Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Egypt.

 

Corresponding author: Eman M. Fahmy, Department of Pediatric, Faculty of Medicine, Sohag University, Sohag, Egypt.
Email: ahmodiemad@yahoo.com

Abstract

Ataxia Telangiectasia (AT) is a very rare autosomal recessive primary immune deficiency (PID) disease that affects 1 in 10,000-40,000 new births per year in the world. It is caused by biallelic mutations in ataxia telangiectasia mutated (ATM) gene and characterized by a progressive cerebellar ataxia. The clinical profile of AT children in Upper Egypt in missing. Herein, we evaluated the clinical characteristics and immunological profiles of patients with AT attending Sohag University Hospital. This was a cross-sectional study, included 21 AT patients attending the Neurological and Immunological Units, Pediatric Department, Sohag University Hospital, starting April 2018 to the end of March 2019. AT represented 20.5% of all PID patients attending the hospital. The most common type of humoral immune deficiency in patients with AT was specific IgA deficiency (52.3%) followed by hypogammaglobulinemia (23.8%). Recurrent sinopulmonary infection with different degrees of severity was the common immunological problem. The most common neurological manifestations in our studied patients, other than the ataxia, were language delay and eye movement abnormalities followed by developmental delay and head nodding. None of our patients had developed malignancy till the end of the study.

Keywords: ataxia telangiectasia; primary immune deficiency, selective IgA deficiency

Date received: 23 January 2021; accepted: 29 September 2021

PMID: 34882376

 

Full Text